CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER

Introduction. Cancer of the oral cavity comprises 6 % of all malignant tumors. Recurrences occur in 15–30  % of patients, 50 % have local recurrences, 25–30  % – regional. The choice of treatment depends on the location and stage of the recurrence.Objective. To choose optimal tactics for surgical tr...

Full description

Bibliographic Details
Main Authors: I. A. Zaderenko, A. M. Mudunov, S. B. Alieva, A. A. Ahundov
Format: Article
Language:Russian
Published: ABV-press 2017-06-01
Series:Opuholi Golovy i Šei
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/261
id doaj-b5f8a63126244608811f068654189e1c
record_format Article
spelling doaj-b5f8a63126244608811f068654189e1c2021-07-29T08:14:11ZrusABV-pressOpuholi Golovy i Šei2222-14682411-46342017-06-0172252910.17650/2222-1468-2017-7-2-25-29242CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCERI. A. Zaderenko0A. M. Mudunov1S. B. Alieva2A. A. Ahundov3N.N. Blokhin Russian Cancer Research Center at the Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center at the Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center at the Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center at the Ministry of Health of RussiaIntroduction. Cancer of the oral cavity comprises 6 % of all malignant tumors. Recurrences occur in 15–30  % of patients, 50 % have local recurrences, 25–30  % – regional. The choice of treatment depends on the location and stage of the recurrence.Objective. To choose optimal tactics for surgical treatment in patients with recurrent cancer of the oropharyngeal region.Materials and methods. The study included 314 patients with recurrent squamous cell carcinoma of the oropharyngeal region, who were treated at the N.N. Blokhin Russian Cancer Research Center and underwent surgical, combination, or conservative treatment.Results. Survival in respect to the time of relapse was 35,0 ± 2.0 % for early (in the course of a year) relapses and 63,0 ± 7.1 % for late (a year after treatment and longer) relapses. Five-year survival in respect to the type of treatment for early recurrences was 34.2 ± 6 % for surgical treatment, 7.7 ± 3.5 % for combination treatment, and 17.6 ± 4.6 % for conservative approach. For late relapses, it was 62.7 ± 5.9 %, 77.8 ± 10.6 %, and 59.2 ± 8.7 %, respectively. Surgical treatment was performed in the form of removal of recurrent tumors, resection and reconstruction using local flaps, extended combined surgeries, and laser or cryodestruction.Conclusion. The method of choice for treatment of recurrent tumors of oropharyngeal cancer is surgery in the form of an extended combined surgery with defect reconstruction using musculocutaneous flaps including the pectoralis major.https://ogsh.abvpress.ru/jour/article/view/261oropharyngeal cancerrecurrencesurgical treatment
collection DOAJ
language Russian
format Article
sources DOAJ
author I. A. Zaderenko
A. M. Mudunov
S. B. Alieva
A. A. Ahundov
spellingShingle I. A. Zaderenko
A. M. Mudunov
S. B. Alieva
A. A. Ahundov
CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER
Opuholi Golovy i Šei
oropharyngeal cancer
recurrence
surgical treatment
author_facet I. A. Zaderenko
A. M. Mudunov
S. B. Alieva
A. A. Ahundov
author_sort I. A. Zaderenko
title CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER
title_short CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER
title_full CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER
title_fullStr CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER
title_full_unstemmed CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER
title_sort choosing options of surgical treatment for reccurent oropharyngeal cancer
publisher ABV-press
series Opuholi Golovy i Šei
issn 2222-1468
2411-4634
publishDate 2017-06-01
description Introduction. Cancer of the oral cavity comprises 6 % of all malignant tumors. Recurrences occur in 15–30  % of patients, 50 % have local recurrences, 25–30  % – regional. The choice of treatment depends on the location and stage of the recurrence.Objective. To choose optimal tactics for surgical treatment in patients with recurrent cancer of the oropharyngeal region.Materials and methods. The study included 314 patients with recurrent squamous cell carcinoma of the oropharyngeal region, who were treated at the N.N. Blokhin Russian Cancer Research Center and underwent surgical, combination, or conservative treatment.Results. Survival in respect to the time of relapse was 35,0 ± 2.0 % for early (in the course of a year) relapses and 63,0 ± 7.1 % for late (a year after treatment and longer) relapses. Five-year survival in respect to the type of treatment for early recurrences was 34.2 ± 6 % for surgical treatment, 7.7 ± 3.5 % for combination treatment, and 17.6 ± 4.6 % for conservative approach. For late relapses, it was 62.7 ± 5.9 %, 77.8 ± 10.6 %, and 59.2 ± 8.7 %, respectively. Surgical treatment was performed in the form of removal of recurrent tumors, resection and reconstruction using local flaps, extended combined surgeries, and laser or cryodestruction.Conclusion. The method of choice for treatment of recurrent tumors of oropharyngeal cancer is surgery in the form of an extended combined surgery with defect reconstruction using musculocutaneous flaps including the pectoralis major.
topic oropharyngeal cancer
recurrence
surgical treatment
url https://ogsh.abvpress.ru/jour/article/view/261
work_keys_str_mv AT iazaderenko choosingoptionsofsurgicaltreatmentforreccurentoropharyngealcancer
AT ammudunov choosingoptionsofsurgicaltreatmentforreccurentoropharyngealcancer
AT sbalieva choosingoptionsofsurgicaltreatmentforreccurentoropharyngealcancer
AT aaahundov choosingoptionsofsurgicaltreatmentforreccurentoropharyngealcancer
_version_ 1721256836028432384